Inactief instrument

Andere talen Veru Inc Nasdaq

Aandelen

US3144621022

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Earnings Flash (VERU) VERU Posts Q2 Revenue $4.1M	08/05
Veru Reports Fiscal 2024 Second Quarter Financial Results and Progress of its Enobosarm High Quality Weight Loss Clinical Program	08/05
Veru to Present at the GLP-1 Based Therapeutics Summit	02/05
Veru to Report Fiscal 2024 Second Quarter Financial Results on May 8, 2024	01/05
Veru : Corporate Presentation, May 2024	30/04
Veru Enrolls First Patients in Phase 2b Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss	30/04
Veru Inc. Enrolls First Patients in Phase 2b Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss	30/04
Veru to Present at the American Association of Clinical Endocrinology (AACE) 2024 Annual Meeting on May 9-11	25/04
Veru Announces Date of 2024 Annual Meeting of Shareholders	01/04
Veru Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	01/04
Veru Reschedules Annual Meeting of Shareholders	25/03
Veru Reschedules Annual Meeting of Shareholders	22/03
Certain Options of Veru Inc. are subject to a Lock-Up Agreement Ending on 13-MAR-2024.	13/03
Certain Common Stock of Veru Inc. are subject to a Lock-Up Agreement Ending on 13-MAR-2024.	13/03
Veru Announces the Appointment of Louis Aronne MD as Chief Medical Advisor for its Enobosarm Program for High Quality Weight Loss	12/03
Veru Inc. Appoints Louis Aronne as Chief Medical Advisor and A Member of the Scientific Advisory Board	12/03
Veru Announces Notification from Nasdaq Related to Delayed Quarterly Report on Form 10-Q	28/02
Healthcare Innovations and Collaborations Fuel Industry Expansion Stocks Under $1 Look Now! OCGN, VTAK, RSCI, VERU, AGEN	21/02
Veru Announces New Scientific Advisory Board for its Enobosarm Program for High Quality Weight Loss	20/02
Veru Inc. Announces New Scientific Advisory Board for Its Enobosarm Program for High Quality Weight Loss	20/02

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Veru Inc Nasdaq

Aandelen

US3144621022

Andere talen

Filters